Trial intelligence / Profile preview

Enterovirus 71 Inactivated Vaccine (Yierlaifu) Batch Consistency and Safety in Infants

CTR20191800Phase 4Active

Sponsor
Sinovac Biotech Ltd.
Start
Sep 2019
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated, sponsored by Sinovac Biotech Ltd.. Started Sep 2019; status: active.

02

Drugs

enterovirus 71 vaccine (vero cell), inactivated

Beyond the preview

Go deeper on CTR20191800.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20191800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call